The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

The WHO’s Director-General described the policy guidelines for Gilead’s twice-yearly drug as the “next best thing” in the ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according to a press release .

Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

While governments have committed to deliver on Sustainable Development Goals by 2030, inequalities, injustices and deadly divide between the Global North and Global South nations (and within rich and ...

Conference on HIV Science officially opened Monday in the Rwandan capital of Kigali, with a strong call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE ...

The World Health Organization (WHO) on Monday recommended countries to use the twice-a-year lenacapavir injection as an add ...

In recent years, Rwanda has made significant strides in the fight against HIV, yet we cannot afford to grow complacent. As highlighted by the Minister of Health ahead of the International AIDS Society ...